Universal Health Services Inc (UHS)
被低估基本面
83
价格
$176.31
市值
$10.46B
第一部分 · 这家公司值多少
概览
Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities in the United States. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric, pharmacy, and/or behavioral health services. It also provides commercial health insurance services; capital resources; and various management services, including central purchasing, information services, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. was founded in 1978 and is headquartered in King of Prussia, Pennsylvania.
No editorial profile for this company yet
Direct competitors
Who this company fights with for the same customers
No editorial profile for this company yet
No competitor list for this company yet.
资产负债表与流动性
营收
$18.11B
最近12个月（截至2026/6/30）
净利润
$1.53B
最近12个月（截至2026/6/30）
自由现金流
$849M
股东权益合计
$7.28B
负债合计
$8.19B
流动比率
1.12
利息覆盖率
13.05
债务/EBITDA
2.01
每股收益
营收与净利润
自由现金流
收入构成
历史财务表
利润率变化
债务变化
债务负担有多重
增长一览表
增长 — 营业收入
公允价值估算
公允价值
$339.97
当前价格
$176.31
安全边际
+48.1%
公允价值区间
$220.98 - $458.96
所用估值方法之间的离散区间，并非经过统计校准的置信区间。
估算方法
估值指标
市盈率（P/E）
7.11
ROE
20.5%
市净率（P/B）
1.20
P/FCF
10.65
毛利率
-
ROIC
12.9%
盈利能力雷达图
价值创造（经济护城河）
ROIC
12.9%
WACC
7.9%
ROIC − WACC
+5.0 pp
ROIC 超过资本成本：公司正在为股东创造价值。
基本面分析标准
通过（22）
- EPS shows upward trend
- EPS CAGR 15.62%
- Price CAGR 5.09%
- ROIC 12.9%
- P/FCF 10.65
- P/B Ratio 1.20
- Debt/Equity ratio
- Operating Margin 11.4%
- Positive Free Cash Flow
- Current Ratio
- Interest Coverage
- Debt/EBITDA
- Return on Tangible Assets
- Price below Graham Number
- ROE 20.8%
- Revenue Growth 5Y 8.5%
- Earnings Surprise avg 4.4%
- PEG Ratio 0.43
- Earnings Quality (OCF/NI) 1.18
- Share Dilution -5.1%
- Net Margin Trend 8.4% vs 7.7%
- Piotroski F-Score 7/9
未通过（4）
- CapEx intensity
- Low reliance on intangibles
- DCF valuation (Unknown)
- Analyst Consensus 35% Buy
不可用（2）
- Gross Margin NaN%
- Dividend Payout NaN%
Piotroski F-评分
财务状况强健
盈利质量
高质量：盈利有现金流支撑
股权稀释
正在回购股份，对股东友好
机构持股
公司治理
管理团队
| 姓名 | 职位 | 年龄 |
|---|---|---|
| Mr. Alan B. Miller | Founder & Executive Chairman of the Board | 87 |
| Mr. Marc D. Miller | CEO, President & Director | 54 |
| Mr. Steve G. Filton | Executive VP, CFO & Secretary | 67 |
| Mr. Edward H. Sim | Executive VP & President of Acute Care Division | 53 |
| Mr. Darren P. Lehrich | Vice President of Investor Relations | 53 |
| Mr. Matthew David Klein | Senior VP & General Counsel | - |
| Ms. Maria Zangardi | Senior VP of Human Resources & Corporate Officer | - |
| Mr. Michael S. Nelson | Senior Vice President of Strategic Services | - |
| Mr. Jim Clark | Senior Vice President of Finance - Acute Care Division | - |
| Thomas Day | Senior Vice President of Finance - Behavioral Health Division | - |
审计风险
9
董事会风险
10
薪酬风险
8
股东权利风险
10
第二部分 · 价格与买入时机
这一部分不判断公司是否值得拥有：它帮助你在基本面说服你之后，选择何时买入。包含：技术分析、潜力、历史回撤、Gamma 敞口。
损益历史
via SEC EDGAR
Latest News
Recent headlines for UHS, sourced from Markets Gazette.